Here, we show that IFN-γ treatment attenuates normal and IPF fibroblast differentiation to the myofibroblast phenotype in vitro more effectively than PFD, illuminating a potential therapeutic strategy. The gene discussed is IFNG; the disease is idiopathic interstitial pneumonia.